Crestline Management

Latest statistics and disclosures from Crestline Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are DNLI, SANA, EGHT, and represent 100.00% of Crestline Management's stock portfolio.
  • Reduced shares in these 10 stocks: IVV (-$377M), , NVDA (-$94M), QQQ (-$77M), AMZN (-$54M), GOOGL (-$44M), JNJ (-$35M), , MSFT (-$30M), IWM (-$26M).
  • Sold out of its positions in ADT, AGCO, AGNC, AES, T, AZZ, ABT, ABBV, ASO, ADTN.
  • Crestline Management was a net seller of stock by $-2.9B.
  • Crestline Management has $63M in assets under management (AUM), dropping by -97.90%.
  • Central Index Key (CIK): 0001536054

Tip: Access up to 7 years of quarterly data

Positions held by Crestline Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Crestline Management

Crestline Management holds 3 positions in its portfolio as reported in the March 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Denali Therapeutics (DNLI) 89.5 $57M -3% 4.2M 13.60
 View chart
Sana Biotechnology (SANA) 7.4 $4.7M -2% 2.8M 1.68
 View chart
8x8 (EGHT) 3.1 $2.0M 991k 2.00
 View chart

Past Filings by Crestline Management

SEC 13F filings are viewable for Crestline Management going back to 2011

View all past filings